Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc
Nanjing (China) and Barcelona (Spain), a global biopharmaceutical company focused on skin health, and Simcere Pharmaceutical Group（2096.HK), an innovation and R&D-driven pharmaceutical
